Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

5.200 -0.360 (-6.47%)
Official Closing Price Updated: 4:15 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zentalis Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 Next >
News headline image
ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024 ↗
ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. 
Via Talk Markets
News headline image
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
From Immunome, Inc.
Via Business Wire
News headline image
Analyst Expectations for Zentalis Pharma's Future ↗
 
Via Benzinga
News headline image
Where Zentalis Pharma Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Expectations for Zentalis Pharma's Future ↗
 
Via Benzinga
News headline image
Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes ↗
 
Via Benzinga
News headline image
Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Where Zentalis Pharma Stands With Analysts ↗
 
Via Benzinga
News headline image
Zentalis Pharma: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More ↗
 
Via Benzinga
News headline image
Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to... 
Via Benzinga
News headline image
Why Shares of Zentalis Pharmaceuticals Dropped This Week ↗
A rash of insider selling meant the stock gave back some of its gains from last week. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 497 companies set new 52-week lows. 
Via Benzinga
News headline image
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)
From Newman Ferrara LLP
Via Business Wire
News headline image
4 Analysts Have This to Say About Zentalis Pharmaceuticals ↗
Zentalis Pharmaceuticals (NASDAQ:ZNTL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Oppenheimer Maintains Outperform Rating for Zentalis Pharmaceuticals: Here's What You Need To Know ↗
Oppenheimer has decided to maintain its Outperform rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) and lower its price target from $80.00 to $50.00. Shares of Zentalis Pharmaceuticals are trading up... 
Via Benzinga
News headline image
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37% ↗
 
Via Benzinga
News headline image
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes ↗
RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday. 
Via Benzinga
News headline image
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
News headline image
Zentalis Pharmaceuticals: Q2 Earnings Insights ↗
  Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. 
Via Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past 30... 
Via FinancialNewsMedia
Topics Death
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
73 Biggest Movers From Yesterday ↗
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.